Biomerica, Inc.
General ticker "BMRA" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $60.2M (TTM average)
Biomerica, Inc. does not follow the US Stock Market performance with the rate: -11.8%.
Estimated limits based on current volatility of 2.1%: low 2.27$, high 2.36$
Factors to consider:
- Total employees count: 64 (+3.2%) as of 2024
- North America accounted for 23.7% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Operating losses, New product viability, Hazardous materials liability, Strategic risks and growth management, Market competition
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-05-31 to 2027-05-31
- 2025-05-31 to 2026-05-31 estimated range: [2.13$, 5.89$]
- 2026-05-31 to 2027-05-31 estimated range: [1.76$, 5.02$]
Financial Metrics affecting the BMRA estimates:
- Positive: with PPE of -2.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -50.64 <= 0.33
- Positive: Shareholder equity ratio, % of 69.05 > 63.39
- Negative: negative Industry operating cash flow (median)
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Investing cash flow per share per price, % of -0.49 > -0.66
- Positive: Inventory ratio change, % of -8.46 <= -0.75
- Negative: negative Net income
Short-term BMRA quotes
Long-term BMRA plot with estimates
Financial data
| YTD | 2023-05-31 | 2024-05-31 | 2025-05-31 |
|---|---|---|---|
| Operating Revenue | $5.34MM | $5.42MM | $5.31MM |
| Operating Expenses | $12.56MM | $11.78MM | $10.45MM |
| Operating Income | $-7.22MM | $-6.37MM | $-5.14MM |
| Non-Operating Income | $0.13MM | $0.43MM | $0.17MM |
| R&D Expense | $1.58MM | $1.49MM | $1.02MM |
| Income(Loss) | $-7.09MM | $-5.94MM | $-4.97MM |
| Taxes | $0.05MM | $0.04MM | $0.00MM |
| Profit(Loss)* | $-7.14MM | $-5.98MM | $-4.97MM |
| Stockholders Equity | $11.72MM | $6.59MM | $4.11MM |
| Inventory | $2.06MM | $2.38MM | $1.49MM |
| Assets | $14.45MM | $9.25MM | $5.95MM |
| Operating Cash Flow | $-5.47MM | $-5.36MM | $-3.84MM |
| Capital expenditure | $0.08MM | $0.12MM | $0.04MM |
| Investing Cash Flow | $-0.08MM | $-0.12MM | $-0.04MM |
| Financing Cash Flow | $9.39MM | $-0.08MM | $2.11MM |
| Earnings Per Share** | $-0.50 | $-0.36 | $-2.16 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.